Roche receives FDA approval for VENTANA MMR RxDx Panel to identify dMMR solid tumour patients
Roche receives FDA approval for VENTANA MMR RxDx Panel to identify dMMR solid tumour patients and pMMR endometrial cancer patients eligible for KEYTRUDA The first-of-its-kind VENTANA MMR RxDx Panel, based on cancer biomarkers, aids in the selection of patients with…